Amy Rogers Filsoof, MD
Internal Medicine · Tucson
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 10 years
- Northwestern University Feinberg Medical School, 2016
Offices
3 locations · Arizona Community Physicians PC · 162 clinicians in this group
Hospitals listed: 037213 · 037248 · St Joseph'S Hospital · Tucson Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Filsoof’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A150946 · Delinquent
Licence status: Delinquent · since 2017 · expires 2025-02-28 · Northwestern University Feinberg School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 86.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- St Joseph'S HospitalTucson, AZAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 50% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.116, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.108, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Tucson Medical CenterTucson, AZAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of TMC Healthcare, which runs 3 hospitalsPatients rate it 2 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.3 (1.06 to 1.53), Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 13.76 (9.5 to 18.03) · 1,880 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.27 (0.76 to 1.77) · 9,373 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.405, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.254, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.183, Oct 2024 – Sep 2025
See every measure and the patient survey for St Joseph'S Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 1 worse of 7 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.116 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.108 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.93 (0 to 1.95) · 578 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.48 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 156 (110.48 to 201.51) · 102 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.9 · 113 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 121 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.2 · 198 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12 · 440 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 2,752 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.01 to 0.43) · 3,786 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.14 to 0.54) · 3,532 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.43 (1.36 to 5.5) · 1,261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.35) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.08 (0.55 to 3.62) · 1,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.17 (0 to 17.68) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.85 (1.62 to 10.07) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.18 to 3.18) · 275 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.22 (0 to 1.01) · 3,176 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 144 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.89 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.1 · 194 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.4 · 268 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 24.8 · 108 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 13.6 · 133 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 193 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 403 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 146 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 103 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 239 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 561 cases | No different | Jan 2024 – Dec 2024 |
What patients said (957 patients answered, 18% of those asked)
| Cleanliness | 2 |
| Nurse communication | 1 |
| Doctor communication | 2 |
| Communication about medicines | 1 |
| Discharge information | 2 |
| Overall hospital rating | 1 |
| Quietness | 2 |
| Recommend hospital | 1 |
| Room was "always" clean | 61% |
| Nurses "always" communicated well | 67% |
| Doctors "always" communicated well | 69% |
| Staff "always" explained | 48% |
| Yes, staff "did" give patients this information | 79% |
| Yes, staff "did" give patients information about help after discharge | 76% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 65% |
| Doctors "always" treated them with courtesy and respect | 77% |
| Patients who gave a rating of "9" or "10" (high) | 51% |
| Staff "always" explained new medications | 61% |
| Nurses "always" explained things so they could understand | 62% |
| Nurses "always" listened carefully | 62% |
| Nurses "always" treated them with courtesy and respect | 76% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 50% |
| Staff "always" explained possible side effects | 35% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
See every measure and the patient survey for Tucson Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.3 (1.06 to 1.53) | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.76 (9.5 to 18.03) · 1,880 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.27 (0.76 to 1.77) · 9,373 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.405 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.254 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.183 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.28 (0.46 to 2.11) · 2,356 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.05 (102.93 to 183.16) · 136 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 108 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.6 · 217 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.1 · 322 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.3 · 566 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18 · 692 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.9 · 586 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.5 · 8,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0.02 to 0.37) · 11,561 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.16 to 0.51) · 11,986 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.49 (0.87 to 4.11) · 3,666 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.99 (0.71 to 3.28) · 1,857 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.45 (1.24 to 3.66) · 3,477 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.63 (2.76 to 8.51) · 1,813 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 901 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 215 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.808 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.846 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.9 · 654 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,110 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 48.2 · 324 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 11.2 · 596 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.3 · 706 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 1,314 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.1 to 7.7) · 57 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.6 (7.1 to 15.8) · 57 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 204 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.8 · 167 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.4 · 513 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.5 to 17.3) · 83 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,266 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,099 patients answered, 24% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 60% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$187,797
Medicare paid this office $187,797 for 625 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 333 | $41,760 | $125 |
| Return visit (30+ min) | 271 | $28,138 | $81 |
| Short return visit (20+ min) | 310 | $24,953 | $59 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 39 | $11,217 | $288 |
| Blood test, thyroid stimulating hormone (tsh) | 427 | $8,181 | $16 |
See all 51 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 333 | $41,760 | $125 |
| Return visit (30+ min) | 271 | $28,138 | $81 |
| Short return visit (20+ min) | 310 | $24,953 | $59 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 39 | $11,217 | $288 |
| Blood test, thyroid stimulating hormone (tsh) | 427 | $8,181 | $16 |
| Insertion of needle into vein for collection of blood sample | 508 | $6,920 | $9 |
| Blood test, lipids (cholesterol and triglycerides) | 416 | $6,234 | $13 |
| Blood test, comprehensive group of blood chemicals | 451 | $5,879 | $10 |
| Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 126 | $5,723 | $45 |
| Vitamin d-3 level | 131 | $4,148 | $29 |
| Influenza vaccine, inactivated | 48 | $3,927 | $82 |
| Prostate cancer screening; prostate specific antigen test (psa) | 159 | $3,008 | $19 |
| Hemoglobin a1c level | 278 | $3,000 | $9 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 328 | $2,466 | $6 |
| Transitional care management services for problem of at least moderate complexity | 12 | $1,913 | $159 |
| Cyanocobalamin (vitamin b-12) level | 106 | $1,685 | $15 |
| New patient visit (45+ min) | 16 | $1,588 | $99 |
| Administration of influenza virus vaccine | 49 | $1,538 | $31 |
| Thyroxine (thyroid chemical), free | 154 | $1,503 | $9 |
| Ferritin (blood protein) level | 87 | $1,432 | $13 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 30 | $1,310 | $41 |
| Transferrin (iron binding protein) level | 84 | $1,263 | $13 |
| Administration of pneumococcal vaccine | 39 | $1,224 | $31 |
| Folic acid level, serum | 60 | $879 | $14 |
| Psa (prostate specific antigen) measurement, total | 42 | $811 | $18 |
| Parathormone (parathyroid hormone) level | 18 | $809 | $40 |
| Aspiration and/or injection of fluid from large joint | 19 | $798 | $42 |
| Psa (prostate specific antigen) measurement, free | 34 | $775 | $18 |
| Iron level | 84 | $640 | $6 |
| Bacterial colony count, urine | 66 | $562 | $8 |
| Blood test, basic group of blood chemicals (calcium, total) | 59 | $555 | $8 |
| Removal of impacted ear wax | 15 | $510 | $32 |
| Manual urinalysis test with examination using microscope, automated | 142 | $470 | $3 |
| Testosterone (hormone) level, total | 15 | $455 | $25 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 51 | $449 | $8 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 29 | $380 | $12 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | 26 | $254 | $8 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 13 | $230 | $18 |
| Urine microalbumin (protein) level | 35 | $215 | $6 |
| Creatinine level to test for kidney function or muscle injury | 35 | $193 | $5 |
| Measurement c-reactive protein for detection of infection or inflammation | 27 | $168 | $5 |
| Bacterial urine culture | 13 | $135 | $8 |
| Injection of drug or substance under skin or into muscle | 11 | $133 | $6 |
| Kidney function blood test panel | 11 | $128 | $9 |
| Bacterial culture for aerobic isolates | 16 | $127 | $8 |
| Phosphate level | 21 | $102 | $5 |
| Magnesium level | 11 | $79 | $7 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 22 | $66 | $3 |
| Microscopic examination for white blood cells with manual cell count | 11 | $60 | $4 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $57 | None |
| Urinalysis, manual test | 14 | $51 | $3 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | – | – | – | – | – | 19 |
| Removal of impacted ear wax | – | – | – | – | – | 16 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
625 Original Medicare patients in 2024. Average age 77 · Women 51% · Health risk score 1.04. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 67% · Coronary heart disease 26% · Cancer 21% · Chronic kidney disease 18% · Atrial fibrillation 18% · Diabetes 16% · Depression 12% · Heart failure 11% · COPD 9% · Stroke 7% · Dementia 4%.
The office billed $462,950, Medicare allowed $219,017 and paid $187,797; for 6,740 services of 126 kinds; $15,886 of it was for drugs given in the office and $171,911 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 625 | 6,740 | 77 | 1.04 | $462,950 | $187,797 |
| 2023 | 254 | 1,039 | 75 | 2.71 | $304,136 | $58,686 |
| 2022 | 166 | 403 | 73 | 2.53 | $223,474 | $32,841 |
| 2021 | 208 | 470 | 70 | 1.30 | $144,981 | $38,014 |
| 2020 | 85 | 156 | 72 | 1.66 | $62,999 | $15,972 |
| 2019 | 31 | 90 | 73 | 3.52 | $38,923 | $10,042 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 78 | $18,152 | $95 |
| Return visit (30+ min) | 111 | $11,676 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 52 | $7,951 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,178 | $132 |
| Hospital discharge day management, more than 30 minutes | 28 | $2,617 | $93 |
| Short return visit (20+ min) | 18 | $1,184 | $62 |
| New patient visit (45+ min) | 11 | $1,155 | $105 |
| Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 14 | $636 | $45 |
| Blood test, thyroid stimulating hormone (tsh) | 32 | $560 | $16 |
| Insertion of needle into vein for collection of blood sample | 52 | $487 | $8 |
| Blood test, lipids (cholesterol and triglycerides) | 31 | $407 | $13 |
| Hemoglobin a1c level | 38 | $381 | $10 |
| Blood test, comprehensive group of blood chemicals | 36 | $373 | $10 |
| Prostate cancer screening; prostate specific antigen test (psa) | 14 | $265 | $19 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 34 | $216 | $6 |
| Cyanocobalamin (vitamin b-12) level | 13 | $192 | $15 |
| Ferritin (blood protein) level | 11 | $147 | $13 |
| Transferrin (iron binding protein) level | 11 | $138 | $13 |
| Iron level | 11 | $70 | $6 |
2022: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $15,816 | $87 |
| Return visit (30+ min) | 43 | $3,592 | $68 |
| Hospital discharge day management, more than 30 minutes | 31 | $2,882 | $90 |
| Long return visit (40+ min) | 29 | $2,668 | $68 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,848 | $168 |
| Follow-up observation care per day, typically 35 minutes | 12 | $1,331 | $89 |
| Short return visit (20+ min) | 12 | $547 | $39 |
2021: 6 services
| Return visit (30+ min) | 146 | $20,771 | $77 |
| New patient visit (45+ min) | 51 | $6,816 | $134 |
| Short return visit (20+ min) | 40 | $2,930 | $57 |
| Long return visit (40+ min) | 25 | $2,728 | $97 |
| Telephone medical discussion with physician, 11-20 minutes | 26 | $1,647 | $59 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,267 | $97 |
2020: 4 services
| Return visit (30+ min) | 24 | $2,188 | $78 |
| New patient visit (45+ min) | 17 | $2,169 | $128 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,282 | $99 |
| Short return visit (20+ min) | 11 | $520 | $43 |
2019: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $4,183 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,713 | $181 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,563 | $98 |
Medicaid work
$592 in 2023
Medicaid paid $592 for 23 billed services this clinician did in 2023, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 23 | $592 |
| 2023 | 23 | 1 | 12 | $592 |
| 2022 | 47 | 2 | 12 | $1,544 |
| 2021 | 28 | 1 | 13 | $956 |
See the largest Medicaid services in earlier years
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 23 | $1,186 |
| Return visit (30+ min) | 24 | $358 |
2021
| Return visit (30+ min) | 28 | $956 |
Drugs they prescribed that Part D paid
$738,086
Pharmacies billed $738,086 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (289 of 7,194) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%. Long-acting opioids: 6% of their opioid prescriptions.
6,295 generic and 861 brand-name prescriptions · $738,086 in drug cost · 123 antibiotic prescriptions to 89 people · 17 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Creon | 15 | $102,079 | $6,805 |
| Eliquis | 80 | $96,604 | $1,208 |
| Ozempic | 50 | $55,411 | $1,108 |
| Mounjaro | 37 | $46,943 | $1,269 |
| Prolia | 21 | $35,909 | $1,710 |
See all 127 drugs
| Creon | 15 | $102,079 | $6,805 |
| Eliquis | 80 | $96,604 | $1,208 |
| Ozempic | 50 | $55,411 | $1,108 |
| Mounjaro | 37 | $46,943 | $1,269 |
| Prolia | 21 | $35,909 | $1,710 |
| Xarelto | 19 | $25,514 | $1,343 |
| Farxiga | 14 | $24,776 | $1,770 |
| Trulicity | 20 | $21,309 | $1,065 |
| Rybelsus | 14 | $16,313 | $1,165 |
| Trelegy Ellipta | 23 | $15,252 | $663 |
| Myrbetriq | 13 | $11,090 | $853 |
| Toujeo Solostar | 11 | $6,366 | $579 |
| Soliqua 100-33 | 11 | $5,512 | $501 |
| Hydrocodone-Acetaminophen | 111 | $4,393 | $40 |
| Levothyroxine | 348 | $3,964 | $11 |
| Omeprazole | 183 | $3,372 | $18 |
| Lantus Solostar | 16 | $3,306 | $207 |
| Symbicort | 11 | $2,979 | $271 |
| Fluticasone-Salmeterol | 17 | $2,928 | $172 |
| Lansoprazole | 14 | $2,824 | $202 |
| Humalog Kwikpen U-100 | 12 | $2,628 | $219 |
| Losartan | 263 | $2,616 | $10 |
| Synthroid | 22 | $2,604 | $118 |
| Estradiol | 64 | $2,552 | $40 |
| Gabapentin | 153 | $2,551 | $17 |
| Rosuvastatin | 267 | $2,489 | $9 |
| Atorvastatin | 228 | $2,373 | $10 |
| Tamsulosin | 134 | $2,362 | $18 |
| Duloxetine | 52 | $2,146 | $41 |
| Butalbital-Acetaminophen-Caffe | 32 | $1,836 | $57 |
| Celecoxib | 29 | $1,830 | $63 |
| Potassium Chloride | 69 | $1,791 | $26 |
| Pantoprazole | 139 | $1,710 | $12 |
| Fluticasone Propionate | 83 | $1,599 | $19 |
| Albuterol Sulfate Hfa | 80 | $1,593 | $20 |
| Zolpidem | 132 | $1,515 | $11 |
| Amlodipine Besylate | 213 | $1,226 | $6 |
| Lidocaine | 12 | $1,204 | $100 |
| Escitalopram | 77 | $1,164 | $15 |
| Simvastatin | 160 | $1,157 | $7 |
| Lisinopril | 156 | $1,154 | $7 |
| Allopurinol | 82 | $1,096 | $13 |
| Azelastine | 48 | $1,093 | $23 |
| Pregabalin | 36 | $1,062 | $29 |
| Oxycodone-Acetaminophen | 40 | $1,050 | $26 |
| Metoprolol | 82 | $1,044 | $13 |
| Triamterene-Hydrochlorothiazid | 77 | $990 | $13 |
| Temazepam | 59 | $890 | $15 |
| Metformin | 91 | $880 | $10 |
| Famotidine | 42 | $830 | $20 |
| Bupropion Xl | 23 | $738 | $32 |
| Carvedilol | 63 | $733 | $12 |
| Paroxetine | 30 | $716 | $24 |
| Pravastatin | 54 | $689 | $13 |
| Naloxone | 12 | $688 | $57 |
| Ropinirole | 27 | $681 | $25 |
| Tramadol | 72 | $659 | $9 |
| Ezetimibe | 24 | $652 | $27 |
| Venlafaxine Hcl Er | 21 | $645 | $31 |
| Lovastatin | 44 | $632 | $14 |
| Ventolin Hfa | 11 | $628 | $57 |
| Valsartan | 19 | $625 | $33 |
| Tizanidine | 39 | $623 | $16 |
| Nebivolol | 19 | $577 | $30 |
| Cyclobenzaprine | 55 | $573 | $10 |
| Valacyclovir | 25 | $554 | $22 |
| Bupropion Hcl Sr | 15 | $553 | $37 |
| Alprazolam | 120 | $533 | $4 |
| Methocarbamol | 23 | $500 | $22 |
| Trazodone | 53 | $499 | $9 |
| Finasteride | 35 | $464 | $13 |
| Amitriptyline | 23 | $459 | $20 |
| Acetaminophen-Codeine | 25 | $453 | $18 |
| Acyclovir | 37 | $439 | $12 |
| Lorazepam | 108 | $433 | $4 |
| Metformin Hcl Er | 44 | $432 | $10 |
| Ibuprofen | 30 | $428 | $14 |
| Alendronate | 65 | $424 | $7 |
| Citalopram Hbr | 50 | $404 | $8 |
| Spironolactone | 34 | $397 | $12 |
| Furosemide | 71 | $394 | $6 |
| Clopidogrel | 33 | $390 | $12 |
| Warfarin | 40 | $386 | $10 |
| Losartan-Hydrochlorothiazide | 25 | $380 | $15 |
| Montelukast | 26 | $371 | $14 |
| Diphenoxylate-Atropine | 12 | $355 | $30 |
| Oxybutynin Chloride | 19 | $353 | $19 |
| Hydrochlorothiazide | 87 | $331 | $4 |
| Sertraline | 36 | $331 | $9 |
| Atenolol | 43 | $324 | $8 |
| Metoprolol | 63 | $319 | $5 |
| Lisinopril-Hydrochlorothiazide | 49 | $319 | $7 |
| Propranolol | 24 | $319 | $13 |
| Clonazepam | 30 | $308 | $10 |
| Olmesartan Medoxomil | 23 | $299 | $13 |
| Buspirone | 28 | $296 | $11 |
| Diazepam | 43 | $285 | $7 |
| Ondansetron | 18 | $273 | $15 |
| Indapamide | 13 | $267 | $21 |
| Glipizide | 27 | $261 | $10 |
| Sumatriptan | 15 | $250 | $17 |
| Naproxen | 24 | $246 | $10 |
| Nitroglycerin | 12 | $228 | $19 |
| Fluoxetine | 22 | $227 | $10 |
| Sulfamethoxazole-Trimethoprim | 33 | $216 | $7 |
| Oxycodone | 23 | $212 | $9 |
| Terazosin | 13 | $206 | $16 |
| Benazepril | 29 | $183 | $6 |
| Nystatin | 12 | $173 | $14 |
| Fenofibrate | 11 | $166 | $15 |
| Pioglitazone | 13 | $164 | $13 |
| Hydroxyzine | 14 | $163 | $12 |
| Ciprofloxacin | 12 | $154 | $13 |
| Doxazosin Mesylate | 11 | $153 | $14 |
| Dicyclomine | 16 | $149 | $9 |
| Meloxicam | 26 | $142 | $5 |
| Ondansetron Odt | 13 | $123 | $9 |
| Paxlovid (Eua) | 11 | $121 | $11 |
| Prednisone | 21 | $106 | $5 |
| Triamcinolone Acetonide | 21 | $105 | $5 |
| Pramipexole Dihydrochloride | 13 | $94 | $7 |
| Clotrimazole | 16 | $93 | $6 |
| Oxybutynin Chloride Er | 13 | $92 | $7 |
| Amoxicillin-Clavulanate Potass | 13 | $86 | $7 |
| Enalapril Maleate | 11 | $71 | $6 |
| Azithromycin | 12 | $39 | $3 |
| Paxlovid | 25 | $0 | $0 |
Year by year
| 2024 | 7,194 | 1,113 | 4% (289) | 12% | $738,086 |
| 2023 | 453 | 199 | 3% (14) | None | $26,689 |
| 2022 | 1,070 | 174 | 2% (17) | None | $89,506 |
| 2021 | 1,156 | 203 | 3% (38) | None | $89,957 |
| 2020 | 145 | 54 | None | 8% | $7,309 |
| 2019 | 31 | 15 | None | None | $930 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Levothyroxine | 19 | $344 | $18 |
| Atorvastatin | 21 | $306 | $15 |
| Losartan | 13 | $244 | $19 |
| Rosuvastatin | 11 | $211 | $19 |
| Gabapentin | 21 | $145 | $7 |
| Amlodipine Besylate | 13 | $133 | $10 |
| Lorazepam | 16 | $82 | $5 |
2022: 28 drugs
| Ozempic | 15 | $17,322 | $1,155 |
| Potassium Chloride | 17 | $5,100 | $300 |
| Atorvastatin | 78 | $817 | $10 |
| Losartan | 61 | $773 | $13 |
| Gabapentin | 47 | $706 | $15 |
| Levothyroxine | 33 | $634 | $19 |
| Tamsulosin | 25 | $579 | $23 |
| Omeprazole | 12 | $562 | $47 |
| Duloxetine | 14 | $548 | $39 |
| Albuterol Sulfate Hfa | 12 | $531 | $44 |
| Rosuvastatin | 16 | $483 | $30 |
| Buspirone | 17 | $445 | $26 |
| Metoprolol | 19 | $430 | $23 |
| Propranolol | 16 | $382 | $24 |
| Famotidine | 25 | $309 | $12 |
| Amlodipine Besylate | 51 | $293 | $6 |
| Alendronate | 29 | $293 | $10 |
| Metformin | 31 | $289 | $9 |
| Pravastatin | 16 | $277 | $17 |
| Metformin Hcl Er | 20 | $223 | $11 |
| Trazodone | 11 | $176 | $16 |
| Fluticasone Propionate | 14 | $125 | $9 |
| Simvastatin | 12 | $112 | $9 |
| Sertraline | 20 | $111 | $6 |
| Lisinopril | 24 | $107 | $4 |
| Meloxicam | 13 | $35 | $3 |
| Hydrochlorothiazide | 11 | $15 | $1 |
| Metoprolol | 13 | $11 | $1 |
2021: 27 drugs
| Eliquis | 12 | $11,392 | $949 |
| Losartan | 76 | $1,231 | $16 |
| Duloxetine | 15 | $1,009 | $67 |
| Atorvastatin | 74 | $886 | $12 |
| Gabapentin | 38 | $843 | $22 |
| Metoprolol | 27 | $694 | $26 |
| Levothyroxine | 31 | $645 | $21 |
| Diclofenac | 20 | $570 | $29 |
| Fluticasone Propionate | 30 | $535 | $18 |
| Rosuvastatin | 15 | $457 | $30 |
| Amlodipine Besylate | 62 | $443 | $7 |
| Metformin Hcl Er | 26 | $440 | $17 |
| Tamsulosin | 16 | $419 | $26 |
| Omega-3 Acid Ethyl Esters | 13 | $389 | $30 |
| Pravastatin | 19 | $378 | $20 |
| Metformin | 35 | $357 | $10 |
| Pantoprazole | 13 | $325 | $25 |
| Omeprazole | 19 | $305 | $16 |
| Valsartan | 12 | $302 | $25 |
| Simvastatin | 23 | $258 | $11 |
| Carvedilol | 17 | $227 | $13 |
| Lisinopril | 28 | $197 | $7 |
| Allopurinol | 13 | $156 | $12 |
| Furosemide | 16 | $140 | $9 |
| Sertraline | 12 | $117 | $10 |
| Alendronate | 26 | $103 | $4 |
| Meloxicam | 16 | $77 | $5 |
2020: 1 drug
| Atorvastatin | 11 | $87 | $8 |
Money from drug and device companies
$1,121 in 2025
| 2025 | 19 | 65 | None | $1,121 |
| 2024 | 19 | 34 | None | $667 |
| 2023 | 7 | 10 | None | $183 |
| 2022 | 1 | 1 | None | $70 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Vraylar | $274 | 15 payments
|
| Pfizer | Prevnar 20 | $106 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Airsupra | $104 | 7 payments
|
| Amgen | Evenity | $102 | 6 payments
|
| Lilly USA | Mounjaro | $73 | 4 payments
|
| Aimmune Therapeutics | Zenpep | $61 | 4 payments
|
See all 65 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-11 | None | $14 |
| Soleno Therapeutics | Meals · 2025-12-09 | Vykat Xr | $25 |
| Abbvie | Meals · 2025-12-05 | Creon | $28 |
| GlaxoSmithKline | Meals · 2025-11-19 | Shingrix | $14 |
| Abbott Laboratories | Meals · 2025-11-19 | Freestyle Libre 3 | $19 |
| Pfizer | Meals · 2025-11-14 | Nurtec Odt | $18 |
| Abbvie | Meals · 2025-11-11 | Vraylar | $17 |
| Aimmune Therapeutics | Meals · 2025-11-07 | Zenpep | $15 |
| Amgen | Meals · 2025-10-28 | Evenity | $15 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-20 | Breztri | $15 |
| Lilly USA | Meals · 2025-10-18 | Kisunla | $18 |
| Abbvie | Meals · 2025-10-16 | Vraylar | $22 |
| Abbvie | Meals · 2025-10-14 | Qulipta | $20 |
| Novo Nordisk | Meals · 2025-10-13 | Rybelsus | $15 |
| Edwards Lifesciences | Meals · 2025-10-10 | Sapien 3 Ultra Resilia | $27 |
| Amgen | Meals · 2025-09-30 | Evenity | $24 |
| Abbvie | Meals · 2025-09-29 | Linzess | $15 |
| Pfizer | Meals · 2025-09-25 | Prevnar 20 | $20 |
| Merck Sharp & Dohme | Meals · 2025-09-22 | Rotateq | $22 |
| Lilly USA | Meals · 2025-09-15 | Mounjaro | $17 |
| Aimmune Therapeutics | Meals · 2025-09-08 | Zenpep | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-04 | Airsupra | $15 |
| Lilly USA | Meals · 2025-08-29 | Kisunla | $17 |
| Eisai | Meals · 2025-08-26 | Leqembi | $19 |
| Abbvie | Meals · 2025-08-25 | Vraylar | $19 |
| Phathom Pharmaceuticals | Meals · 2025-08-18 | Voquezna | $14 |
| Novo Nordisk | Meals · 2025-08-04 | None | $16 |
| Pfizer | Meals · 2025-07-22 | Prevnar 20 | $16 |
| Abbvie | Meals · 2025-07-18 | Linzess | $17 |
| Amgen | Meals · 2025-07-14 | Repatha | $16 |
| GlaxoSmithKline | Meals · 2025-07-11 | Shingrix | $14 |
| Abbott Laboratories | Meals · 2025-07-11 | Freestyle Libre 3 | $18 |
| Abbvie | Meals · 2025-07-08 | Vraylar | $14 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-06-30 | Xifaxan | $15 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-27 | Airsupra | $15 |
| Lilly USA | Meals · 2025-06-26 | Mounjaro | $20 |
| Pfizer | Meals · 2025-06-17 | Prevnar 20 | $19 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-06-16 | Jardiance | $14 |
| Globus Medical | Meals · 2025-06-10 | Senza | $17 |
| Aimmune Therapeutics | Meals · 2025-06-09 | Zenpep | $16 |
| Pfizer | Meals · 2025-05-31 | Nurtec Odt | $17 |
| GlaxoSmithKline | Meals · 2025-05-30 | Shingrix | $16 |
| Gilead Sciences | Meals · 2025-05-23 | Epclusa | $15 |
| Abbvie | Meals · 2025-05-19 | Qulipta | $22 |
| Amgen | Meals · 2025-05-15 | Evenity | $16 |
| GlaxoSmithKline | Meals · 2025-05-12 | Shingrix | $14 |
| Abbvie | Meals · 2025-05-12 | Vraylar | $17 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-09 | Kerendia | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-05 | Airsupra | $14 |
| Abbvie | Meals · 2025-05-01 | Linzess | $21 |
| Phathom Pharmaceuticals | Meals · 2025-04-25 | Voquezna | $12 |
| Merck Sharp & Dohme | Meals · 2025-04-24 | Rotateq | $21 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-04-10 | None | $25 |
| Abbvie | Meals · 2025-04-01 | Vraylar | $14 |
| Pfizer | Meals · 2025-02-28 | Nurtec Odt | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-25 | Airsupra | $15 |
| Abbvie | Meals · 2025-02-24 | Vraylar | $18 |
| Amgen | Meals · 2025-02-20 | Evenity | $16 |
| Amgen | Meals · 2025-02-18 | Otezla | $15 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-17 | Airsupra | $16 |
| Abbvie | Meals · 2025-02-07 | Linzess | $9 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-04 | Kerendia | $13 |
| Aimmune Therapeutics | Meals · 2025-01-31 | Zenpep | $14 |
| Globus Medical | Meals · 2025-01-30 | Senza | $20 |
| Abbvie | Meals · 2025-01-23 | Qulipta | $22 |
See earlier years (2024, 2023, 2022)
2024: $667
| Abbvie | Vraylar | $111 | 6 payments
|
| Amgen | Evenity | $83 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Airsupra | $51 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $46 | 2 payments
|
| Novo Nordisk | Rybelsus | $43 | 3 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $36 | 2 payments
|
| Astellas Pharma US | Veozah | $31 | 1 payment
|
| Aimmune Therapeutics | Zenpep | $30 | 2 payments
|
| Phathom Pharmaceuticals | Voquezna | $30 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $26 | 1 payment
|
| Collegium Pharmaceutical | Xtampza | $25 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $24 | 1 payment
|
| Lilly USA | Mounjaro | $23 | 1 payment
|
| Boston Scientific | Watchman Flx | $22 | 1 payment
|
| Corcept Therapeutics | Korlym | $21 | 1 payment
|
| Gilead Sciences | Epclusa | $17 | 1 payment
|
| Nevro | Senza | $17 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $16 | 1 payment
|
| Axsome Therapeutics | Auvelity | $16 | 1 payment
|
2023: $183
| GlaxoSmithKline | Shingrix | $78 | 4 payments
|
| Amgen | Otezla | $23 | 1 payment
|
| Abbvie | Vraylar | $20 | 1 payment
|
| Lilly USA | Jardiance | $17 | 1 payment
|
| Pfizer | Nurtec Odt | $17 | 1 payment
|
| Almatica Pharma | Loreev Xr | $15 | 1 payment
|
| Novo Nordisk | None | $14 | 1 payment
|
2022: $70
| Intuitive Surgical | Da Vinci Surgical System | $70 | 1 payment
|
Professional record
- NPI
- 1033508874
- Licence
- AZ 70560, CA A150946California A150946: Delinquent · expires 2025-02-28
- Trained
- Northwestern University Feinberg Medical School, 2016 · 10 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X); Hospitalist (208M00000X); Student in a training program (390200000X)
- Mailing address
- 4801 E Broadway Blvd Ste 251, Tucson, AZ, 85711
- NPI first listed
- 2015-01-16
- NPI last updated
- 2026-06-24
- NPI record certified
- 2026-06-24
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1250 16th St, Santa Monica, CA, 90404 · 300 Pasteur Dr, Stanford, CA, 94305